To evaluate the immunological responses to seasonal influenza vaccines in patients with compensated and decompensated liver cirrhosis, specifically comparing these responses to those of healthy individuals.
Key Findings:
Patients with liver cirrhosis exhibited stronger vaccine-induced immune responses compared to healthy individuals, highlighting the clinical significance of these findings.
Enhanced cell-mediated immune responses were observed in cirrhosis patients post-vaccination, indicating a robust immune activation.
Vaccination response was stronger in patients with advanced, decompensated liver cirrhosis, suggesting a unique immune profile.
Distinct serum cytokine and metabolite profiles linked to systemic inflammation differentiated decompensated from compensated cirrhosis and healthy individuals, providing insights into immune mechanisms.
Interpretation:
Patients with liver cirrhosis can mount an efficient immune response to seasonal influenza vaccines, with systemic inflammation potentially enhancing these responses in advanced stages of cirrhosis, warranting further investigation into the underlying mechanisms.
Limitations:
Limited sample size and potential selection bias in patient recruitment may affect the generalizability of the findings.
The observational nature of the study may limit causal inferences, necessitating further research to confirm these results.
Conclusion:
Influenza vaccination is effective in patients with liver cirrhosis, particularly in advanced stages, suggesting that systemic inflammation may play a role in enhancing immune responses. Future studies should explore the mechanisms behind these enhanced responses.
by Janyn Heisig, Valerie Ohlendorf, Nhan Nguyen, Peggy Riese, Stephanie Trittel, Liang Zhou, Ahmed Alaswad, Heiner Wedemeyer, Anke Kraft, Yang Li, Markus Cornberg, Carlos A. Guzmán, Benjamin Maasoumy
